Encision Inc. Stock

ECIA

US29254Q1040

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets Other stock markets 17:30:32 16/07/2026 +04			5-day change	1st Jan Change
0.0452 ^USD	+35.33%		+2,913.33%	-67.71%

12-13	Encision Inc. Announces Management Changes	CI
12-13	Encision Inc. Announces CEO Changes	CI

Encision Inc. is a medical device company. It designs, develops, manufactures and markets patented surgical instruments that provide safety to patients undergoing minimally invasive surgery. Its segments include Product and Service. The Product segment designs, develops, manufactures and markets patented surgical instruments. The Service segment performs electrical engineering activities for external entities. Its Active Electrode Monitoring (AEM) technology provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures, while preventing stray electrosurgical energy that can cause tissue injury that may result in death. The AEM system consists of shielded 5mm AEM Instruments and an AEM monitor. Laparoscopic instruments have the integrated AEM design and include the full range of instruments that are common in laparoscopic surgery. The AEM monitor is compatible with electrosurgical generators.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
16/07/26	$0.0452	+35.33%	2,000

Delayed Quote OTC Markets

More quotes

Income Statement and Estimates

More financial data

Stock Market
Stocks
ECIA Stock

Google lets you customize your preferred sources.

Choose MarketScreener

Market Cap	2.19M 1.92M 1.77M 1.63M 3.08M 211M 3.13M 21.15M 8.31M 103M 8.24M 8.06M 356M	P/E 2024	-12.5x	P/E 2025	-23.9x
Enterprise Value	3.25M 2.84M 2.63M 2.41M 4.56M 313M 4.64M 31.34M 12.31M 153M 12.21M 11.94M 528M	EV / Sales 2024	1.54x	EV / Sales 2025	1.03x
Free-Float	35.96%	Yield 2024 *	-	Yield 2025	-

12-13	Encision Inc. Announces Management Changes	CI
12-13	Encision Inc. Announces CEO Changes	CI
11-14	Encision Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
11-04	Encision Inc. Announces Resignation of Patrick Pace from Its Board of Directors, Effective October 30, 2025	CI
19/08/25	Encision Inc. announced that it has received $0.5 million in funding	CI
15/08/25	Encision Inc. Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
11/07/25	Encision Inc. Reports Earnings Results for the Full Year Ended March 31, 2025	CI
15/02/25	Encision Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
15/11/24	Earnings Flash (ECIA) ENCISION Reports Fiscal Q2 Revenue $1.8M	MT
15/11/24	Encision Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	CI
15/08/24	Encision Inc. Reports Earnings Results for the First Quarter Ended June 30, 2024	CI
15/07/24	Earnings Flash (ECIA) ENCISION Reports Q4 Revenue $1.5M	MT
15/07/24	Encision Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

07-16	Encision : Announces Start of Stock Trading	PU
07-14	Encision Inc. Announces Start of Stock Trading	AQ
05-04	Encision Inc. Announces Halt of Stock Trading	AQ
04-13	Encision Inc. Announces Fiscal 2026 Fourth Quarter and Full Year Results	AQ
01-30	Encision : Announces Decision to Deregister its Common Stock	PU

1 day	+35.33%
1 week	+2,913.33%
Current month	+2,913.33%
1 month	+2,913.33%
3 months	-77.51%
6 months	-73.44%
Current year	-67.71%

1 week	0.03	0.05
1 month	0.03	0.05
Current year	0	0.2
1 year	0	0.4
3 years	0	0.75
5 years	0	1.5
10 years	0	1.5

Encision Inc. Stock

Stocks

ECIA

US29254Q1040

Medical Equipment, Supplies & Distribution

Valuation: Encision Inc.

Chart: Encision Inc.

Latest news : Encision Inc.

Press Releases: Encision Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Encision Inc.

Latest insider transactions

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

Income Statement and Estimates

Manager	Title	Age	Since
Robert Fries CEO	Chief Executive Officer	77	08/12/2025
Brandon Shepard DFI	Director of Finance/CFO	42	01/08/2024
Jason Johnson SAM	Sales & Marketing	51	01/10/2022

Director	Title	Age	Since
Vern Kornelsen BRD	Director/Board Member	93	01/01/1991
Robert Fries BRD	Director/Board Member	77	17/04/2024

Date	Insider	Type	Main position	Quantity	% Market Cap.
15/04/26	Robert Fries	Buy	Chief Executive Officer	166,785	0.9881%
18/11/25	Vern Kornelsen	Free	Founder	10,000	0.0592%
18/11/25	Brian Jackman	Free	VP of Marketing	10,000	0.0592%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ENCISION INC.	+35.33%	+2,913.33%	-87.65%	-89.24%	763K
ABBOTT LABORATORIES	+10.71%	+4.69%	-24.98%	-8.43%	172B
MEDTRONIC PLC	+3.84%	+1.42%	-6.93%	-4.67%	107B
CENCORA, INC.	+3.85%	+1.83%	+3.41%	+60.90%	59.92B
BECTON, DICKINSON AND COMPANY	+3.26%	+6.02%	-10.29%	-38.34%	44.07B
MEDLINE INC.	+4.23%	+0.64%	-	-	34.76B
DEXCOM, INC.	+7.22%	+6.79%	-7.31%	-43.21%	30.09B
WEST PHARMACEUTICAL SERVICES, INC.	+0.96%	+1.34%	+61.53%	-5.89%	25.61B
SARTORIUS STEDIM BIOTECH	+0.75%	+3.00%	-2.13%	-17.59%	20.86B
STERIS PLC	+4.57%	+2.38%	-2.85%	-3.47%	21.55B
Average	+6.05%	+2.94%	-8.58%	-16.66%	51.6B
Weighted average by Cap.	+1.80%	+3.37%	-8.40%	-3.92%

	2024	2025
Net sales	6.59M 5.76M 5.32M 4.89M 9.25M 635M 9.41M 63.49M 24.94M 310M 24.73M 24.19M 1.07B	6.56M 5.73M 5.3M 4.86M 9.2M 632M 9.36M 63.2M 24.83M 308M 24.62M 24.08M 1.06B
Net income	-692K -605K -559K -513K -971K -66.66M -988K -6.67M -2.62M -32.55M -2.6M -2.54M -112M	-220K -192K -178K -163K -309K -21.22M -315K -2.12M -834K -10.36M -827K -809K -35.77M
Net Debt	1.29M 1.13M 1.04M 957K 1.81M 124M 1.84M 12.44M 4.89M 60.73M 4.85M 4.74M 210M	1.06M 924K 854K 784K 1.48M 102M 1.51M 10.19M 4M 49.73M 3.97M 3.88M 172M